Immunomodulatory and antioxidant effects of saffron aqueous extract (Crocus sativus L.) on streptozotocin-induced diabetes in rats
暂无分享,去创建一个
[1] S. Samarghandian,et al. Anticarcinogenic effect of saffron (Crocus sativus L.) and its ingredients , 2014, Pharmacognosy research.
[2] R. Afshari,et al. Evaluation of Lung and Bronchoalveolar Lavage Fluid Oxidative Stress Indices for Assessing the Preventing Effects of Safranal on Respiratory Distress in Diabetic Rats , 2014, TheScientificWorldJournal.
[3] S. Samarghandian,et al. Effects of Cichorium intybus linn on blood glucose, lipid constituents and selected oxidative stress parameters in streptozotocin-induced diabetic rats. , 2014, Cardiovascular & hematological disorders drug targets.
[4] S. Samarghandian,et al. Safranal ameliorates antioxidant enzymes and suppresses lipid peroxidation and nitric oxide formation in aged male rat liver , 2013, Biogerontology.
[5] M. Golechha,et al. Crocus sativus L. (saffron) attenuates isoproterenol-induced myocardial injury via preserving cardiac functions and strengthening antioxidant defense system. , 2012, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.
[6] M. Golechha,et al. Akt/GSK-3β/eNOS phosphorylation arbitrates safranal-induced myocardial protection against ischemia–reperfusion injury in rats , 2012, European Journal of Nutrition.
[7] M. Hashizume,et al. Atherogenic effects of TNF-α and IL-6 via up-regulation of scavenger receptors. , 2012, Cytokine.
[8] H. Sadeghnia,et al. Effects of Saffron (Crocus sativus L.) and its Active Constituent, Crocin, on Recognition and Spatial Memory after Chronic Cerebral Hypoperfusion in Rats , 2012, Phytotherapy research : PTR.
[9] S. Funk,et al. Hyperglycemia and Endothelial Dysfunction in Atherosclerosis: Lessons from Type 1 Diabetes , 2012, International journal of vascular medicine.
[10] H. Sahraei,et al. Saffron (Crocus sativus) Aqueous Extract and its Constituent Crocin Reduces Stress‐induced Anorexia in Mice , 2011, Phytotherapy research : PTR.
[11] Mohajeri Daryoush,et al. Attenuation of oxidative stress of hepatic tissue by ethanolic extract of saffron (dried stigmas of Crocus sativus L.) in streptozotocin (STZ)-induced diabetic rats , 2011 .
[12] S. Kianbakht,et al. Anti-hyperglycemic Effects of Saffron and its Active Constituents, Crocin and Safranal, in Alloxan-Induced Diabetic Rats , 2011 .
[13] W. Mayhan,et al. Chronic resveratrol treatment restores vascular responsiveness of cerebral arterioles in type 1 diabetic rats. , 2011, American journal of physiology. Heart and circulatory physiology.
[14] Maria Tsachaki,et al. Memory enhancing effects of saffron in aged mice are correlated with antioxidant protection , 2011, Behavioural Brain Research.
[15] S. Samarghandian,et al. Suppression of Pulmonary Tumor Promotion and Induction of Apoptosis by Crocus sativus L. Extraction , 2011, Applied biochemistry and biotechnology.
[16] S. Srichairatanakool,et al. Effects of Phenolic Compounds of Fermented Thai Indigenous Plants on Oxidative Stress in Streptozotocin-Induced Diabetic Rats , 2011, Evidence-based complementary and alternative medicine : eCAM.
[17] Enas A. Hamed,et al. Vasculopathy in type 2 diabetes mellitus: role of specific angiogenic modulators , 2011, Journal of Physiology and Biochemistry.
[18] L. Chuang,et al. The role of oxidative stress in the pathogenesis of type 2 diabetes: from molecular mechanism to clinical implication. , 2010, American journal of translational research.
[19] C. Apovian,et al. Reduced adipose tissue inflammation represents an intermediate cardiometabolic phenotype in obesity. , 2009, Journal of the American College of Cardiology.
[20] N. Calcutt,et al. Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials , 2009, Nature Reviews Drug Discovery.
[21] Srijit Das,et al. The Effects of Palm Oil Tocotrienol-Rich Fraction Supplementation on Biochemical Parameters, Oxidative Stress and the Vascular Wall of Streptozotocin-Induced Diabetic Rats , 2009, Clinics.
[22] S. Bakker,et al. Does the metabolic syndrome add to the diagnosis and treatment of cardiovascular disease? , 2008, Nature Clinical Practice Cardiovascular Medicine.
[23] R. de Cabo,et al. Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations. , 2008, American journal of physiology. Heart and circulatory physiology.
[24] M. Fowler. Microvascular and Macrovascular Complications of Diabetes , 2008, Clinical Diabetes.
[25] A. Ardestani,et al. Experimental diabetes treated with Achillea santolina: effect on pancreatic oxidative parameters. , 2007, Journal of ethnopharmacology.
[26] N. Agrawal,et al. Atherosclerosis in diabetes mellitus: role of inflammation. , 2007, Indian journal of medical sciences.
[27] Min Yang,et al. Crocetin prevents AGEs-induced vascular endothelial cell apoptosis. , 2006, Pharmacological research.
[28] Z. Ungvari,et al. Resveratrol attenuates TNF-α-induced activation of coronary arterial endothelial cells: role of NF-κB inhibition , 2006 .
[29] H. Hosseinzadeh,et al. EFFECTS OF CROCUS SATIVUS STIGMA EXTRACT AND ITS CONSTITUENTS, CROCIN AND SAFRANAL, ON INTACT MEMORY AND SCOPOLAMINE-INDUCED LEARNING DEFICITS IN RATS PERFORMING THE MORRIS WATER MAZE TASK , 2006 .
[30] L. Sheng,et al. Mechanism of hypolipidemic effect of crocin in rats: crocin inhibits pancreatic lipase. , 2006, European journal of pharmacology.
[31] L. Hung,et al. Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. , 2006, American journal of physiology. Endocrinology and metabolism.
[32] A. Assimopoulou,et al. Radical scavenging activity of Crocus sativus L. extract and its bioactive constituents , 2005, Phytotherapy research : PTR.
[33] J. Coresh,et al. Glycemic control, atherosclerosis, and risk factors for cardiovascular disease in individuals with diabetes: the atherosclerosis risk in communities study. , 2005, Diabetes care.
[34] Z. Ungvari,et al. Role of oxidative and nitrosative stress, longevity genes and poly(ADP-ribose) polymerase in cardiovascular dysfunction associated with aging. , 2005, Current vascular pharmacology.
[35] R. Natarajan,et al. Lipid inflammatory mediators in diabetic vascular disease. , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[36] R. Virmani,et al. Morphologic Findings of Coronary Atherosclerotic Plaques in Diabetics: A Postmortem Study , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[37] M. Brownlee. A radical explanation for glucose-induced β cell dysfunction , 2003 .
[38] J. Navarro,et al. Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[39] N. Baquer,et al. Alterations in antioxidant enzymes and oxidative damage in experimental diabetic rat tissues: Effect of vanadate and fenugreek (Trigonella foenum graecum) , 2002, Molecular and Cellular Biochemistry.
[40] H. Hosseinzadeh,et al. Antinociceptive and anti-inflammatory effects of Crocus sativus L. stigma and petal extracts in mice , 2002, BMC pharmacology.
[41] M. Brownlee. Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.
[42] I. Goldberg. Diabetic Dyslipidemia: Causes and Consequences , 2001 .
[43] G. Pacini,et al. Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. , 2000, Diabetes.
[44] M. El-Missiry,et al. Enhanced testicular antioxidant system by ascorbic acid in alloxan diabetic rats. , 1999, Comparative biochemistry and physiology. Part C, Pharmacology, toxicology & endocrinology.
[45] M. Netea,et al. High glucose concentrations increase the tumor necrosis factor-alpha production capacity by human peripheral blood mononuclear cells. , 1998, Romanian journal of physiology : physiological sciences.
[46] M. Ravid,et al. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. , 1998, Archives of internal medicine.
[47] J. Reyes,et al. Prevention of alloxan-induced diabetes mellitus in the rat by silymarin. , 1998, Comparative biochemistry and physiology. Part C, Pharmacology, toxicology & endocrinology.
[48] M. Recio,et al. An Update Review of Saffron and its Active Constituents , 1996 .
[49] G. Pieper,et al. Peroxidative Stress in Diabetic Blood Vessels: Reversal by Pancreatic Islet Transplantation , 1995, Diabetes.
[50] A. Gotlieb,et al. Expression of tumour necrosis factor alpha and accumulation of fibronectin in coronary artery restenotic lesions retrieved by atherectomy. , 1995, British heart journal.
[51] M. Díaz-Guerra,et al. Nitric oxide is released in regenerating liver after partial hepatectomy , 1995, Hepatology.
[52] M. Cybulsky,et al. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. , 1991, Science.
[53] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[54] S. Marklund,et al. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. , 1974, European journal of biochemistry.
[55] G. Ellman,et al. Tissue sulfhydryl groups. , 1959, Archives of biochemistry and biophysics.
[56] R. Afshari,et al. Expression of Concern Expression of Concern on “Crocus sativus L. (Saffron) Stigma Aqueous Extract Induces Apoptosis in Alveolar Human Lung Cancer Cells through Caspase-Dependent Pathways Activation” , 2019 .
[57] C. Stefanadis,et al. Diabetes mellitus and vascular endothelial dysfunction: current perspectives. , 2012, Current vascular pharmacology.
[58] A. Aliyev,et al. EFFECTS OF HYDROMETHANOLIC EXTRACT OF SAFFRON (CROCUS SATIVUS) ON SERUM GLUCOSE, INSULIN AND CHOLESTEROL LEVELS IN HEALTHY MALE RATS , 2010 .
[59] T. Dunning. Periodontal disease--the overlooked diabetes complication. , 2009, Nephrology nursing journal : journal of the American Nephrology Nurses' Association.
[60] Z. Ungvari,et al. Resveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells: role of NF-kappaB inhibition. , 2006, American journal of physiology. Heart and circulatory physiology.
[61] A. Ergul,et al. Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. , 2005, Cardiovascular diabetology.
[62] Niacin A N D Riboflavin. Disturbances of micronutrient and antioxidant status in diabetes , 2005 .
[63] M. Brownlee. A radical explanation for glucose-induced beta cell dysfunction. , 2003, The Journal of clinical investigation.
[64] A. Ortiz,et al. Involvement of tumor necrosis factor-alpha in the pathogenesis of experimental and human glomerulonephritis. , 1995, Advances in nephrology from the Necker Hospital.
[65] H. Aebi,et al. Catalase in vitro. , 1984, Methods in enzymology.